It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHGCF’s FA Score shows that 0 FA rating(s) are green whileCHGCY’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHGCF’s TA Score shows that 5 TA indicator(s) are bullish while CHGCY’s TA Score has 5 bullish TA indicator(s).
CHGCF (@Pharmaceuticals: Major) experienced а +13.73% price change this week, while CHGCY (@Pharmaceuticals: Major) price change was +1.64% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.16%. For the same industry, the average monthly price growth was +3.94%, and the average quarterly price growth was +10.41%.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
CHGCF | CHGCY | CHGCF / CHGCY | |
Capitalization | 73.6B | 73.6B | 100% |
EBITDA | 556B | 556B | 100% |
Gain YTD | 12.773 | 1.274 | 1,002% |
P/E Ratio | 28.98 | 27.41 | 106% |
Revenue | 1.2T | 1.2T | 100% |
Total Cash | 1.03T | 1.03T | 100% |
Total Debt | N/A | N/A | - |
CHGCF | CHGCY | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 3 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | 26 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 99 | |
PRICE GROWTH RATING 1..100 | 84 | 81 | |
P/E GROWTH RATING 1..100 | 69 | 66 | |
SEASONALITY SCORE 1..100 | 65 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CHGCY's Valuation (26) in the null industry is somewhat better than the same rating for CHGCF (63). This means that CHGCY’s stock grew somewhat faster than CHGCF’s over the last 12 months.
CHGCY's Profit vs Risk Rating (100) in the null industry is in the same range as CHGCF (100). This means that CHGCY’s stock grew similarly to CHGCF’s over the last 12 months.
CHGCY's SMR Rating (99) in the null industry is in the same range as CHGCF (99). This means that CHGCY’s stock grew similarly to CHGCF’s over the last 12 months.
CHGCY's Price Growth Rating (81) in the null industry is in the same range as CHGCF (84). This means that CHGCY’s stock grew similarly to CHGCF’s over the last 12 months.
CHGCY's P/E Growth Rating (66) in the null industry is in the same range as CHGCF (69). This means that CHGCY’s stock grew similarly to CHGCF’s over the last 12 months.
CHGCF | CHGCY | |
---|---|---|
RSI ODDS (%) | N/A | 1 day ago68% |
Stochastic ODDS (%) | 1 day ago53% | 1 day ago79% |
Momentum ODDS (%) | 1 day ago47% | 1 day ago75% |
MACD ODDS (%) | 1 day ago56% | 1 day ago75% |
TrendWeek ODDS (%) | 1 day ago34% | 1 day ago72% |
TrendMonth ODDS (%) | 1 day ago39% | 1 day ago73% |
Advances ODDS (%) | 1 day ago55% | 1 day ago73% |
Declines ODDS (%) | 23 days ago74% | 4 days ago78% |
BollingerBands ODDS (%) | 1 day ago64% | 1 day ago74% |
Aroon ODDS (%) | 1 day ago46% | N/A |
A.I.dvisor tells us that CHGCF and CHGCY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCF and CHGCY's prices will move in lockstep.
Ticker / NAME | Correlation To CHGCF | 1D Price Change % | ||
---|---|---|---|---|
CHGCF | 100% | +9.42% | ||
CHGCY - CHGCF | 32% Poorly correlated | +0.27% | ||
CMOPF - CHGCF | 10% Poorly correlated | N/A | ||
DSKYF - CHGCF | -2% Poorly correlated | -1.93% | ||
CHJTF - CHGCF | -3% Poorly correlated | N/A | ||
DSNKY - CHGCF | -5% Poorly correlated | -1.06% | ||
More |
A.I.dvisor tells us that CHGCY and CHGCF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCY and CHGCF's prices will move in lockstep.
Ticker / NAME | Correlation To CHGCY | 1D Price Change % | ||
---|---|---|---|---|
CHGCY | 100% | +0.27% | ||
CHGCF - CHGCY | 32% Poorly correlated | +9.42% | ||
OTSKY - CHGCY | 30% Poorly correlated | +2.67% | ||
OPHLY - CHGCY | 22% Poorly correlated | +0.52% | ||
DSNKY - CHGCY | 22% Poorly correlated | -1.06% | ||
RHHBY - CHGCY | 20% Poorly correlated | +0.61% | ||
More |